Ads
related to: pfizer- Quality by Design
A holistic, proactive approach
to drug development. Learn more.
- Biologics Development
Increase batch yield and reduce
processing time.
- Quality by Design
Search results
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters via AOL· 5 days agoThe company has been locked in a legal battle with Pfizer-BioNTech over their COVID shot Comirnaty...
China-Based Asymchem Laboratories Will Operate Former Pfizer Manufacturing Facility in UK
Morningstar· 15 hours agoBy Adriano Marchese Asymchem Laboratories (TianJin) said it will operate the former small molecule active pharmaceutical pilot plant that belonged to Pfizer UK, expanding ...
3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With Less Than $100 Right Now
Motley Fool via Yahoo Finance· 2 days agoIf you have an extra $100 to invest, you could set yourself up with dividends from Realty Income...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via Yahoo Finance· 6 days agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
Benzinga· 15 hours agoRelated: Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With...
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
Reuters· 4 days ago, opens new tab $107.5 million in damages, a Delaware federal jury said on Friday after finding that...
UPDATE 1-Pfizer offers up to $250 mln to settle Zantac cancer lawsuits, FT reports
Reuters via Yahoo Finance· 6 days agoPfizer will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its discontinued heartburn drug Zantac, the Financial Times reported ...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters· 5 days agoModerna said on Friday the European Patent Office had upheld the validity of one of the company's...
This overlooked obesity-drug stock has 80% upside, JPMorgan says
Business Insider via Yahoo Finance· 7 hours agoJPMorgan said early results suggest the drug candidate offers "on par" weight loss results for...
2 Top Growth Stocks Down 24% and 50% to Buy With $100 | The Motley Fool
The Motley Fool· 6 days agoThe healthcare industry is full of opportunities for long-term investors to become part-owner in compelling businesses that are changing the future for patients across countless disease areas ...